Analytic considerations in applying a general economic evaluation reference case to gene therapy

Drummond, M.F. orcid.org/0000-0002-6126-0944, Neumann, P., Sullivan, S. et al. (4 more authors) (2019) Analytic considerations in applying a general economic evaluation reference case to gene therapy. Value in Health. pp. 661-668. ISSN 1524-4733

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019, ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy.
Keywords: cost-effectiveness analysis;, drug pricing;, reimbursement, specialty drugs
Dates:
  • Accepted: 27 March 2019
  • Published: 12 June 2019
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
Depositing User: Pure (York)
Date Deposited: 28 Mar 2019 11:50
Last Modified: 06 Dec 2023 13:02
Published Version: https://doi.org/10.1016/j.jval.2019.03.012
Status: Published
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jval.2019.03.012

Download

Filename: MFD_PN_SS_etc_Analytc_aply_econ_eval_ref_gene_therapy_submtd_ViH_March2019.pdf

Description: MFD PN SS etc Analytc aply econ eval ref gene therapy submtd ViH March2019

Licence: CC-BY-NC-ND 2.5

Export

Statistics